The US government, through the United States Agency for International Development (USAID), in partnership with ExxonMobil PNG, the Motu-Koita Assembly, and the National Capital District Provincial Health Authority (NCD PHA) has launched a second mobile vaccination clinic in Port Moresby to support the deployment of COVID-19 vaccines last Friday.
This second mobile vaccination clinic joins the recognizable ‘big yellow bus’ operated by the Motu-Koita Assembly and will deliver COVID-19 vaccines directly to residents of the National Capital District (NCD), targeting small villages and facilities .
The bus will maintain a constant supply of COVID-19 vaccines donated through the COVAX facility.
The United States remains the largest contributor to COVAX, providing US $ 4 billion to support the global effort to provide safe and effective vaccines to 92 countries, including Papua New Guinea.
PNG has already received 580,400 doses of vaccine from the COVAX facility, including 302,400 Johnson & Johnson vaccines donated by the US government.
U.S. Ambassador to Papua New Guinea, Solomon Islands and Vanuatu Erin McKee was joined by Australian High Commissioner to Papua New Guinea Jon Philp, Speaker of the Motu-Koita Assembly and NCD Deputy Governor Dadi Toka Jr, Executive Director Peter Larden of ExxonMobil and Party Leader Dr. Ignatius Mogaba of USAID’s implementing partner, FHI 360, to initiate the rollout of immunization clinics.
“The US government is steadfast in its support for the PNG government to vaccinate as many of Papua New Guinea as possible.
The addition of this mobile clinic provides another more convenient way for NCD residents to get vaccinated, ”Ambassador McKee said.
“We urge all residents of Port Moresby to be on the lookout for these ‘big yellow buses’ in your community and get vaccinated to protect yourself, your families and your wantok.”
To date, the US government, through USAID, has provided more than US $ 11.7 million to fight COVID-19 in PNG.
This aid is part of a global campaign by the United States to mitigate the COVID-19 pandemic and support equitable access to vaccines for the world’s most vulnerable.